» Articles » PMID: 32042677

A Mutational Profile in Multiple Thymic Squamous Cell Carcinoma

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2020 Feb 12
PMID 32042677
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiple thymic squamous cell carcinoma (TSCC) is a rare thymic epithelial tumor with a dismal prognosis. Mutational profiles of multiple TSCC may expand our understanding of tumorigenesis and treatment options for these tumors.

Methods: We sequenced the whole exomes of 3 TSCC nodules from a multiple TSCC patient and a paired peripheral blood sample and identified single-nucleotide variants and small insertions and deletions, and also performed gene ontological and pathway analyses.

Results: The 3 TSCC nodules were subjected to hematoxylin-eosin staining, and the results showed that these 3 nodules were highly similar with respect to histology. We identified 116, 94 and 98 non-synonymous somatic mutations in the 3 TSCC nodules, and 34 mutations, including mutations in and , among others, were present in all 3 TSCC nodules. We then performed immunohistochemistry to assess two selected genes, and , and found that the 3 TSCC nodules expressed similar levels of and . Further gene ontological analysis and pathway analysis revealed that the 3 TSCC nodules also had similar significantly enriched pathways based on the identified genetic alterations. These results demonstrated that the 3 multiple TSCC nodules were spatially independent of each other but were highly similar with respect to histological sources and genetic characteristics, suggesting that 2 TSCC nodules were likely metastases of the third nodule.

Conclusions: These findings suggest that TSCC cells can be transferred to other sites inside the thymus and that total thymectomy is a good treatment option for thymic epithelial tumors.

Citing Articles

Modified subcostal arch xiphoid thoracoscopic expanded thymectomy for thymic carcinoma: a case report and review of literature.

Wang J, Liu Y, Zhuang W, Zhao Y J Cardiothorac Surg. 2022; 17(1):234.

PMID: 36088333 PMC: 9463808. DOI: 10.1186/s13019-022-01981-w.

References
1.
Jiang J, Liu Y, Ke A, Gu F, Yu Y, Dai Z . Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing. Hepatology. 2014; 59(6):2216-27. DOI: 10.1002/hep.27012. View

2.
Shitara M, Okuda K, Suzuki A, Tatematsu T, Hikosaka Y, Moriyama S . Genetic profiling of thymic carcinoma using targeted next-generation sequencing. Lung Cancer. 2014; 86(2):174-9. DOI: 10.1016/j.lungcan.2014.08.020. View

3.
Ishibashi H, Akamatsu H, Sunamori M . Multiple thymoma with myasthenia gravis: report of a case. Surg Today. 2003; 33(1):49-51. DOI: 10.1007/s005950300008. View

4.
Hu Z, Wang J, Yao T, Hong R, Zhang K, Gao H . Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication. Lung Cancer. 2013; 81(1):27-31. DOI: 10.1016/j.lungcan.2013.04.006. View

5.
Asao T, Fujiwara Y, Sunami K, Kitahara S, Goto Y, Kanda S . Medical treatment involving investigational drugs and genetic profile of thymic carcinoma. Lung Cancer. 2016; 93:77-81. DOI: 10.1016/j.lungcan.2016.01.004. View